None
Quote | Gamida Cell Ltd. (NASDAQ:GMDA)
Last: | $0.0327 |
---|---|
Change Percent: | -20.8% |
Open: | $0.0395 |
Close: | $0.0327 |
High: | $0.0395 |
Low: | $0.032 |
Volume: | 23,036,893 |
Last Trade Date Time: | 04/05/2024 03:00:00 am |
News | Gamida Cell Ltd. (NASDAQ:GMDA)
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
2024-04-03 06:21:00 ET How to Analyze Different Penny Stocks Sectors to Make Money Investing in penny stocks offers an accessible entry point for individuals aiming to participate in the stock market with a lower initial investment. Analyzing different sectors within the realm of penn...
Message Board Posts | Gamida Cell Ltd. (NASDAQ:GMDA)
Subject | By | Source | When |
---|---|---|---|
Gamida: The Die Is Now Cast | midastouch017 | investorshub | 04/28/2023 8:04:57 PM |
Looks as if we caught a down elevator today. | turning stone | investorshub | 04/28/2023 6:15:25 PM |
What direction will we go tomorrow?? | midastouch017 | investorshub | 04/28/2023 4:47:09 AM |
Well we got on the elevator today and | turning stone | investorshub | 04/27/2023 10:40:08 PM |
looks like a cup and handle formation going | MEBHAR | investorshub | 04/26/2023 10:03:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Gamida Cell Ltd. Company Name:
GMDA Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfu...
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...